Carried by: French Study Group of Cutaneous Lymphoma
References:
Clinician(s): Marie BEYLOT-BARRY
Biologist(s): Audrey GROS
Presentation
Criteria before considering a discussion in MDM-FMG
Criteria: clinical criteria of aggressiveness only (rapid progression, extent of lesions, ≥ T2, general signs, etc.) without any other criteria
Entities concerned:
- Main: Diffuse large cutaneous B-cell lymphomas leg-type that are refractory or recurrent after first-line R-C(H)OP
- Others (rarer) :
- Refractory or recurrent centrofollicular cutaneous B-cell lymphomas
- Diffuse large cutaneous B-cell lymphomas not classified as leg-type or centrofollicular type (pcDLBCL-NOS).
- Transformation into large cells of primary small cell cutaneous B-cell lymphomas (centrofollicular or marginal zone) if this transformation is associated with criteria of aggressiveness
Genome Sequencing in diagnostic strategy
MDM cartography
MDM
Type of the MDM
City of the coordinator
Name, first name, and email of the contact
MDM FMG Solid Tumors adults CHU Bordeaux
Regional
Bordeaux
Bordeaux :
Jean-Philippe MERLIO
jean-philippe.merlio@chu-bordeaux.fr
Referent biologists : Audrey GROS, Anaëlle ISNARD
MDM FMG Solid Tumors adults APHP
Regional
Paris
Paris :
Pierre-Laurent PUIG
pierre.laurent-puig@parisdescartes.fr
Referent biologists : Fanélie JOENNE, Maxence MANCINI